Ida Leah Gitajn1, Marilyn Heng, Michael J Weaver, Natalie Casemyr, Collin May, Mark S Vrahas, Mitchel B Harris. 1. *Harvard Combined Orthopaedic Residency Program, Boston, MA; †Department of Orthopaedic Surgery, Harvard Medical School Orthopedic Trauma Initiative, Massachusetts General Hospital, Boston, MA; and ‡Department of Orthopaedic Surgery, Harvard Medical School Orthopedic Trauma Initiative, Brigham and Women's Hospital, Boston, MA.
Abstract
OBJECTIVES: The goals of this study are to evaluate mortality after Vancouver B periprosthetic fractures and determine predictors of mortality; compare mortality among patients with loose femoral stems treated with revision arthroplasty versus fixation alone; compare mortality among patients with radiographically "indeterminate" fractures treated with revision or fixation; and evaluate the rate of return to surgery for patients who underwent revision compared with fixation. DESIGN: Retrospective study. SETTING: Three academic level 1 trauma centers. PATIENTS/PARTICIPANTS: Two hundred three patients treated for Vancouver B periprosthetic fractures. INTERVENTION: N/A. MAIN OUTCOME MEASUREMENTS: The primary outcome measure was mortality. The secondary outcome measure was reoperation because of infection, failure of fixation, dislocation, or other mechanical failure. RESULTS: Overall 1-year survival was 87% and 5-year survival was 54%. Among patients with loose femoral stems, there was no significant difference with regard to survival between patients treated with fracture fixation or revision arthroplasty (1-year survival 83% vs. 85%, 5-year survival 41% vs. 58%). Among patients whose radiographs were classified as indeterminate, there was no significant difference between patients treated with fracture fixation alone or revision arthroplasty. There was no significant difference between total reoperation rates between the two groups (11% vs. 16%). CONCLUSION: This study suggests that there is no discernible survival benefit to treating patients with periprosthetic fractures with either revision arthroplasty or fixation alone. Therefore, from a mortality perspective, when faced with Vancouver B periprosthetic fractures, the orthopaedic surgeon should feel comfortable performing the type of intervention he/she is most proficient to perform. LEVEL OF EVIDENCE: Prognostic level III. See Instructions for Authors for a complete description of levels of evidence.
OBJECTIVES: The goals of this study are to evaluate mortality after Vancouver B periprosthetic fractures and determine predictors of mortality; compare mortality among patients with loose femoral stems treated with revision arthroplasty versus fixation alone; compare mortality among patients with radiographically "indeterminate" fractures treated with revision or fixation; and evaluate the rate of return to surgery for patients who underwent revision compared with fixation. DESIGN: Retrospective study. SETTING: Three academic level 1 trauma centers. PATIENTS/PARTICIPANTS: Two hundred three patients treated for Vancouver B periprosthetic fractures. INTERVENTION: N/A. MAIN OUTCOME MEASUREMENTS: The primary outcome measure was mortality. The secondary outcome measure was reoperation because of infection, failure of fixation, dislocation, or other mechanical failure. RESULTS: Overall 1-year survival was 87% and 5-year survival was 54%. Among patients with loose femoral stems, there was no significant difference with regard to survival between patients treated with fracture fixation or revision arthroplasty (1-year survival 83% vs. 85%, 5-year survival 41% vs. 58%). Among patients whose radiographs were classified as indeterminate, there was no significant difference between patients treated with fracture fixation alone or revision arthroplasty. There was no significant difference between total reoperation rates between the two groups (11% vs. 16%). CONCLUSION: This study suggests that there is no discernible survival benefit to treating patients with periprosthetic fractures with either revision arthroplasty or fixation alone. Therefore, from a mortality perspective, when faced with Vancouver B periprosthetic fractures, the orthopaedic surgeon should feel comfortable performing the type of intervention he/she is most proficient to perform. LEVEL OF EVIDENCE: Prognostic level III. See Instructions for Authors for a complete description of levels of evidence.
Authors: Peter Biberthaler; Patrick Pflüger; Markus Wurm; Marc Hanschen; Chlodwig Kirchhoff; Joseph Aderinto; George Whitwell; Peter V Giannoudis; Nikolaos Kanakaris Journal: J Orthop Trauma Date: 2022-02-11 Impact factor: 2.884
Authors: Jonathan N Lamb; Oliver Coltart; Isaiah Adekanmbi; Hemant G Pandit; Todd Stewart Journal: Proc Inst Mech Eng H Date: 2022-05-21 Impact factor: 1.763
Authors: Katelyn Ragland; Rebecca Reif; Saleema Karim; Kevin W Sexton; Steven M Cherney; Jeffrey B Stambough; Simon C Mears Journal: Geriatr Orthop Surg Rehabil Date: 2020-07-19
Authors: Karl Stoffel; Michael Blauth; Alexander Joeris; Andrea Blumenthal; Elke Rometsch Journal: Arch Orthop Trauma Surg Date: 2020-02-21 Impact factor: 3.067